ATE262342T1 - Substance p behandlung zur immunostimulierung - Google Patents

Substance p behandlung zur immunostimulierung

Info

Publication number: ATE262342T1
Authority: AT; Austria
Prior art keywords: substance; treatment; immuno; immune; aerosols
Prior art date: 1996-07-23

Application number

AT97938049T

Other languages

English (en)

Inventor

Mark L Witten

David T Harris

Original Assignee

Mark L Witten

David T Harris

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-23

Filing date

1997-07-08

Publication date

2004-04-15

1997-07-08 Application filed by Mark L Witten, David T Harris filed Critical Mark L Witten

2004-04-15 Application granted granted Critical

2004-04-15 Publication of ATE262342T1 publication Critical patent/ATE262342T1/de

Links

238000011282 treatment Methods 0.000 title abstract 3
230000003308 immunostimulating effect Effects 0.000 title 1
239000000126 substance Substances 0.000 title 1
210000000987 immune system Anatomy 0.000 abstract 3
QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract 2
102100024304 Protachykinin-1 Human genes 0.000 abstract 2
101800003906 Substance P Proteins 0.000 abstract 2
239000000443 aerosol Substances 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
230000001010 compromised effect Effects 0.000 abstract 1
231100001238 environmental toxicant Toxicity 0.000 abstract 1
229930195733 hydrocarbon Natural products 0.000 abstract 1
150000002430 hydrocarbons Chemical class 0.000 abstract 1
230000036737 immune function Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000035800 maturation Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97938049T 1996-07-23 1997-07-08 Substance p behandlung zur immunostimulierung ATE262342T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US2206396P	1996-07-23	1996-07-23
US08/829,445 US5945508A (en)	1996-07-23	1997-03-28	Substance P treatment for immunostimulation
PCT/US1997/013146 WO1998003194A2 (en)	1996-07-23	1997-07-08	Substance p treatment for immunostimulation

Publications (1)

Publication Number	Publication Date
ATE262342T1 true ATE262342T1 (de)	2004-04-15

Family

ID=26695449

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97938049T ATE262342T1 (de)	1996-07-23	1997-07-08	Substance p behandlung zur immunostimulierung

Country Status (8)

Country	Link
US (2)	US5945508A (de)
EP (1)	EP0957930B1 (de)
AT (1)	ATE262342T1 (de)
AU (1)	AU737201B2 (de)
CA (1)	CA2261885A1 (de)
DE (1)	DE69728294T2 (de)
ES (1)	ES2215236T3 (de)
WO (1)	WO1998003194A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6573244B1 (en) *	1999-05-17	2003-06-03	The United States Of America As Represented By The Secretary Of The Army	Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
WO2002009738A1 (en)	2000-07-28	2002-02-07	Murphy Christopher J	Transplant media
IT1317895B1 (it) *	2000-08-10	2003-07-15	Univ Napoli Federico Ii	Pseudo-metalloproteine, loro preparazione e loro uso.
WO2002102835A2 (en) *	2000-11-21	2002-12-27	New England Medical Center	Novel antimicrobial compounds
US6437093B1 (en) *	2000-11-28	2002-08-20	Milkhaus Laboratory, Inc.	Methods of treatment comprising administration of Substance P
WO2004019865A2 (en) *	2002-08-27	2004-03-11	Witten Mark L	Amelioration of effects of cigarette smoke
US20060153789A1 (en) *	2002-12-18	2006-07-13	Witten Mark L	Stimulation of hair regrowth
EP1613337A4 (de) *	2003-04-14	2008-03-26	Immuneregen Biosciences Inc	Akute respiratorische syndrome
US20070207209A1 (en) *	2004-08-27	2007-09-06	Murphy Christopher J	Trophic factor combinations for nervous system treatment
US20060069086A1 (en) *	2004-09-23	2006-03-30	Alexander Michalow	Methods for regulating neurotransmitter systems by inducing counteradaptations
KR100593397B1 (ko) *	2004-10-27	2006-06-28	한국원자력연구소	중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
AU2005299341A1 (en) *	2004-10-27	2006-05-04	Immuneregen Biosciences, Inc.	Method to promote wound healing
SG123646A1 (en) *	2005-01-05	2006-07-26	Immuneregen Biosciences Inc	Prevention of respiratory infections in fowl
US20080194487A1 (en) *	2005-01-12	2008-08-14	Witten Mark L	Treatment of Skin Diseases
SG126014A1 (en) *	2005-04-01	2006-10-30	Immuneregen Biosciences Inc	Treatment of asthma
US20060281670A1 (en) *	2005-06-10	2006-12-14	Wisconsin Alumni Research Foundation (Warf)	Compositions and methods for modulating angiogenesis
US20070154448A1 (en)	2005-11-22	2007-07-05	Ted Reid	Methods and compositions using Substance P to promote wound healing
JP2009536919A (ja) *	2006-03-10	2009-10-22	イムムネレゲンビオスシエンセス，インコーポレーテッド	炭疽菌感染の危険性及び／又は重症度を低減する方法
WO2008036157A2 (en) *	2006-08-15	2008-03-27	Immuneregen Biosciences, Inc.	Prophylactic and therapeutic treatment of avian influenza infections in animals
EP2125869A2 (de) *	2007-01-18	2009-12-02	Immuneregen Biosciences, Inc.	Substanz p und analoga davon als hilfsstoff einer immunogenen zusammensetzung
US8321012B2 (en)	2009-12-22	2012-11-27	The Invention Science Fund I, Llc	Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5410019A (en) *	1987-09-24	1995-04-25	The Administrators Of The Tulane-Educational Fund	Therapeutic peptides
US5256765A (en) *	1989-03-09	1993-10-26	The Johns Hopkins University School Of Medicine	Biodegradable poly(phosphate esters)
EP0586532A4 (en) *	1991-05-24	1994-08-17	Univ Northwestern	Method of using substance p to treat allergy
EP0545478A1 (de) *	1991-12-03	1993-06-09	MERCK SHARP & DOHME LTD.	Heterocyclische Verbindungen als Tachykininantagoniste
DE69523154T2 (de) *	1994-06-06	2002-06-06	Warner-Lambert Co., Morris Plains	Tachykinin (nk1) rezeptor antagonisten

1997
- 1997-03-28 US US08/829,445 patent/US5945508A/en not_active Expired - Lifetime
- 1997-07-08 ES ES97938049T patent/ES2215236T3/es not_active Expired - Lifetime
- 1997-07-08 WO PCT/US1997/013146 patent/WO1998003194A2/en not_active Ceased
- 1997-07-08 AU AU40464/97A patent/AU737201B2/en not_active Ceased
- 1997-07-08 CA CA002261885A patent/CA2261885A1/en not_active Abandoned
- 1997-07-08 DE DE69728294T patent/DE69728294T2/de not_active Expired - Fee Related
- 1997-07-08 EP EP97938049A patent/EP0957930B1/de not_active Expired - Lifetime
- 1997-07-08 AT AT97938049T patent/ATE262342T1/de not_active IP Right Cessation
1998
- 1998-02-23 US US09/028,003 patent/US5998376A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0957930A2 (de)	1999-11-24
WO1998003194A3 (en)	1998-06-18
ES2215236T3 (es)	2004-10-01
AU4046497A (en)	1998-02-10
DE69728294D1 (de)	2004-04-29
US5998376A (en)	1999-12-07
EP0957930B1 (de)	2004-03-24
CA2261885A1 (en)	1998-01-29
US5945508A (en)	1999-08-31
WO1998003194A2 (en)	1998-01-29
AU737201B2 (en)	2001-08-09
DE69728294T2 (de)	2004-08-19

Similar Documents

Publication	Publication Date	Title
DE69728294D1 (de)	2004-04-29	Substance p behandlung zur immunostimulierung
DE69408032D1 (de)	1998-02-26	Vorrichtung zur Verminderung des Laufgeräusches von Fahrzeugen
MX9302011A (es)	1994-03-31	Derivados de indol.
PT804196E (pt)	2003-01-31	Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
ATE415172T1 (de)	2008-12-15	Behinderung der unterdrückung von t lymphozyten im zusammenhang mit der ctla-4 signalübertragung
DK0587616T3 (da)	1996-08-12	Tætningsindretning især kabeltætning
ATE193647T1 (de)	2000-06-15	Di- und trivalente kleine moleküle als selektininhibitoren
BG40955A3 (en)	1987-03-14	Acaricide means and method for protection from acars
DE69426419D1 (de)	2001-01-18	Silylierte Polyamin-Polymere als Schmiermittel mit und ohne andere Komponenten, mit den Polymeren behandelte Substrate und Verfahren zur Behandlung der Substrate
TR200000374T2 (tr)	2000-09-21	Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
BG101105A (bg)	1998-04-30	Заместени бензамидини, тяхното получаване и използването им като лекарствени средства
NZ326754A (en)	2000-03-27	The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders
DE69105868D1 (de)	1995-01-26	Verfahren zur Reibungsminderung in Gasrohrleitungen.
DE69120942D1 (de)	1996-08-22	Hilfsstoffzusammensetzungen in fester form, dispergieren in wässerigen medien
ES2079068T3 (es)	1996-01-01	2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas.
DE69200684D1 (de)	1994-12-22	Vorrichtung zur thermischen Behandlung von laufenden Garnen.
ES2096988T3 (es)	1997-03-16	Organopolisiloxanos que contienen grupos hidrofilos.
NO890046D0 (no)	1989-01-05	Disubstituerte pyridiner.
ATE162794T1 (de)	1998-02-15	Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
DE69231384D1 (de)	2000-09-28	Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms
ATE168274T1 (de)	1998-08-15	Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind
DE59309740D1 (de)	1999-09-23	Lyopilisierte, wirkstoffhaltige emulsion
BG100248A (bg)	1996-07-31	Инхибитори на скваленсинтетаза
ATE285789T1 (de)	2005-01-15	Mukosale zytotoxische t-lymphozytenantwort
NL1000138C2 (nl)	1996-10-15	Inrichtingen voor het bewerken van een substraat alsmede werkwijze geschikt voor toepassing bij dergelijke inrichtingen.

Legal Events

Date	Code	Title	Description
2004-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties